Rohit Bapurav Sonar

Title: Rohit Bapurav Sonar: Innovator in Vaccine Composition

Introduction

Rohit Bapurav Sonar is a notable inventor based in Pune, Maharashtra, India. He has made significant contributions to the field of immunology, particularly in the development of stable vaccine compositions. His work focuses on enhancing the viability and stability of vaccines, which is crucial for effective immunization.

Latest Patents

Rohit Bapurav Sonar holds a patent for "Stable vaccine compositions comprising inter alia live attenuated recombinant flavivirus and process for preparation thereof." This innovative patent describes stable lyophilized immunogenic compositions that include live attenuated recombinant flaviviruses, specifically targeting dengue viruses. The composition is designed to preserve the desired characteristics of the virus, including viability, immunogenicity, and stability, while being devoid of preservatives, polymers, and surfactants. The methods for manufacturing these stable compositions are also outlined in the patent.

Career Highlights

Rohit is currently associated with the Serum Institute of India Private Limited, a leading organization in vaccine production. His work at the institute has been pivotal in advancing vaccine technology and ensuring public health safety through effective immunization strategies.

Collaborations

Rohit collaborates with esteemed colleagues such as Rajeev Mhalasakant Dhere and Leena Ravindra Yeolekar. Their combined expertise contributes to the innovative research and development efforts at the Serum Institute of India.

Conclusion

Rohit Bapurav Sonar's contributions to vaccine composition and immunology are noteworthy. His patent reflects a significant advancement in the field, promising improved vaccine stability and efficacy. His work continues to impact public health positively.